Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc down on Tuesday (RX)

Automated Summaries - The Globe and Mail - Tue Apr 30, 4:02PM CDT

In trading today, Biosyent Inc shares closed at $8.60 after opening the day at $8.69. prices ranged from a low of $8.60 to a high of $8.69.

The price eased -0.35 percent from the previous day's close of $8.63.

During the day across North America, the TSX Composite closed -1.35% at 21714.54, the S&P 500 closed 0.32% at 5116.17, the Dow Jones Industrial Average closed 0.38% at 38386.09 and the Nasdaq Composite closed 0.35% at 15983.08.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

A total of 504 shares was traded during the session, with total trades of 3, with an average volume of 18,579 over the last 5 days.

The TSX-V overall saw 1,288 price advancers against 3,926 declines and 104 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have boosted 13.16 percent in the last 12 months, while this year, they have dipped -6.72%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.15 million on a float of 11,605 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe